Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 61
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 68
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 71
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 09:12 UTC
  • 70
  • 0 comments

Revance Therapeutics (RVNC) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 66
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Revance Therapeutics, Inc. - Common Stock. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Cellectar Biosciences Inc. (CLRB)

  • Technical Exchange News
  • Feb. 07, 2025, 02:52 UTC
  • 67
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 00:56 UTC
  • 62
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Revance Therapeutics, Inc. - Common Stock. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text
  • Previous
  • 427
  • 428
  • 429
  • 430
  • 431
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284475)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162162)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin